Alumis (ALMS) Financials: Revenue & Earnings

ALMS price $6.98 +0.34 +5.12%

Ticker
ALMS
Price
$6.98
Change
+0.34 +5.12%
Market cap ?
$903.46M
P/E ?
-1.78
Forward P/E ?
4.01
Dividend yield ?
0.00%
Beta ?
-0.67
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
47
Value
58
Quality
34
Growth
50

Stocklytics score rationale: value 58, quality 34, growth 50.

Financials

2022202320242025
00024050000

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory…

Fair value

ALMS fair value $68.09. Price $6.98. Price is 90% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare ALMS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.73—1.90M
2026-08-13-1.11-0.771.66M3.65M
2026-05-14-0.74-0.741.74M2.06M
2026-03-19-0.95-0.971.93M2.36M
2025-11-13-1.06-0.922.07M2.75M
2025-08-13-1.17-1.112.67M3.14M
2025-05-14-1.82-1.4717.39M1.67M
2025-03-19-1.74-1.40—1.00M
2024-11-13-1.73-1.64——
2024-08-13-1.47-1.46——
2024-06-07-4.50———
2023-12-31-4.50———
2023-09-30-1.13———
2023-06-29-0.70———
2023-03-31-0.69———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-08AKKARAJU SRINIVASBuy273.29K$10.632.90M
2026-09-08AKKARAJU SRINIVASSell48.07K$10.55507.02K
2026-09-08AKKARAJU SRINIVASBuy273.29K$10.632.90M
2026-09-08AKKARAJU SRINIVASSell48.06K$10.55507.01K
2026-09-04AKKARAJU SRINIVASBuy220.07K$11.172.46M
2026-09-04AKKARAJU SRINIVASBuy220.07K$11.172.46M
2026-08-03Schroer John R.Sell3.28K$26.3786.55K
2026-08-03Pangali SanamSell1.36K$26.3735.97K
2026-08-03Hardiman Roy C.Sell2.69K$26.3770.99K
2026-08-03Goldstein David MSell2.60K$26.3768.46K
2026-08-03Drappa JornSell2.45K$26.3764.53K
2026-08-03Bradley Mark ChristopherSell2.57K$26.3767.82K
2026-07-06Pangali SanamSell5.00K$5.0625.30K
2026-07-06Pangali SanamBuy5.00K$5.0625.30K
2026-07-06Pangali SanamSell5.00K$28.00140.00K
2026-06-30TETRAULT LYNN A.Buy15.53K$28.14436.96K
2026-06-30TETRAULT LYNN A.Buy3.55K——
2026-06-30Yao ZhengbinBuy3.55K——
2026-06-30Yao ZhengbinBuy15.53K$28.14436.96K
2026-06-30Srivastava SapnaBuy15.53K$28.14436.96K
2026-06-30Srivastava SapnaBuy3.55K——
2026-06-30Machado PatrickBuy15.53K$28.14436.96K
2026-06-30Machado PatrickBuy3.55K——
2026-06-30AKKARAJU SRINIVASBuy15.53K$28.14436.96K
2026-06-30AKKARAJU SRINIVASBuy3.55K——
2026-05-22Drappa JornSell15.54K$5.0678.61K
2026-05-22Drappa JornSell11.32K$8.84100.04K
2026-05-22Drappa JornBuy15.54K$5.0678.61K
2026-05-22Drappa JornBuy11.32K$8.84100.04K
2026-04-01Foresite Labs, LLCBuy1.12M——
2026-04-01Foresite Labs, LLCBuy680.49K——
2026-04-01Foresite Labs, LLCSell1.12M——
2026-04-01Foresite Capital Management VI LLCBuy1.12M——
2026-04-01Foresite Capital Management VI LLCBuy680.49K——
2026-04-01Foresite Capital Management VI LLCSell1.12M——
2026-04-01Tananbaum James B.Buy1.12M——
2026-04-01Tananbaum James B.Buy680.49K——
2026-04-01Tananbaum James B.Sell1.12M——
2026-01-26Pangali SanamBuy186.20K$26.314.90M
2026-01-26Babler MartinBuy745.88K$26.3119.62M
2026-01-26Hardiman Roy C.Buy190.88K$26.315.02M
2026-01-26Bradley Mark ChristopherBuy190.22K$26.315.00M
2026-01-26Drappa JornBuy221.45K$26.315.83M
2026-01-26Schroer John R.Buy202.22K$26.315.32M
2026-01-26Goldstein David MBuy216.68K$26.315.70M
2026-01-09AKKARAJU SRINIVASBuy588.24K$17.0010.00M
2026-01-08Foresite Labs, LLCBuy117.65K$17.002.00M
2026-01-08Foresite Labs, LLCBuy294.12K$17.005.00M
2026-01-08Foresite Capital Management VI LLCBuy117.65K$17.002.00M
2026-01-08Foresite Capital Management VI LLCBuy294.12K$17.005.00M
2026-01-08Tananbaum James B.Buy117.65K$17.002.00M
2026-01-08Tananbaum James B.Buy294.12K$17.005.00M
2025-12-31Goldstein David MOther0——
2025-12-31Goldstein David MOther0——
2025-12-31Goldstein David MOther0——
2025-12-05AKKARAJU SRINIVASBuy51.38K$10.73551.31K
2025-12-05AKKARAJU SRINIVASBuy70.03K$10.01700.98K
2025-12-05AKKARAJU SRINIVASBuy64.97K$8.95581.47K
2025-12-04AKKARAJU SRINIVASBuy66.03K$8.18540.10K
2025-12-03AKKARAJU SRINIVASBuy100.00K$7.75775.00K
2025-12-02AKKARAJU SRINIVASBuy96.00K$7.55724.80K
2025-12-01AKKARAJU SRINIVASBuy86.35K$7.46644.17K
2025-11-28AKKARAJU SRINIVASBuy38.70K$7.64295.68K
2025-11-26AKKARAJU SRINIVASBuy48.54K$7.64370.82K
2025-11-21Foresite Capital Management VI LLCBuy72.21K$7.38532.92K
2025-11-21Tananbaum James B.Buy72.21K$7.38532.92K
2025-11-21Foresite Labs, LLCBuy72.21K$7.38532.92K
2025-11-20AKKARAJU SRINIVASBuy125.74K$7.20905.35K
2025-11-19Foresite Labs, LLCBuy190.50K$6.561.25M
2025-11-19Foresite Capital Management VI LLCBuy190.50K$6.561.25M
2025-11-19Tananbaum James B.Buy190.50K$6.561.25M
2025-11-19AKKARAJU SRINIVASBuy137.77K$6.56903.78K
2025-11-18Foresite Labs, LLCBuy117.37K$6.19726.55K
2025-11-18Foresite Capital Management VI LLCBuy117.37K$6.19726.55K
2025-11-18Tananbaum James B.Buy117.37K$6.19726.55K
2025-11-18AKKARAJU SRINIVASBuy102.65K$6.05621.04K
2025-11-17Foresite Labs, LLCBuy150.00K$5.59838.50K
2025-11-17Foresite Labs, LLCBuy50.00K$5.60280.00K
2025-11-17Foresite Capital Management VI LLCBuy150.00K$5.59838.50K
2025-11-17Foresite Capital Management VI LLCBuy50.00K$5.60280.00K
2025-11-17Tananbaum James B.Buy150.00K$5.59838.50K
2025-11-17Tananbaum James B.Buy50.00K$5.60280.00K
2025-11-17AKKARAJU SRINIVASBuy914$5.515.04K
2025-11-13AKKARAJU SRINIVASBuy276.18K$5.251.45M
2025-09-25Goldstein David MSell1.00K——
2025-07-30TETRAULT LYNN A.Buy49.80K$4.10204.18K
2025-07-30Yao ZhengbinBuy49.80K$4.10204.18K
2025-07-30Srivastava SapnaBuy49.80K$4.10204.18K
2025-07-30Machado PatrickBuy49.80K$4.10204.18K
2025-07-30AKKARAJU SRINIVASBuy49.80K$4.10204.18K
2025-07-29Pangali SanamBuy40.00K$3.95158.00K
2025-07-29Pangali SanamBuy10.00K——
2025-07-29Richardson DerrickBuy64.20K$3.95253.59K
2025-07-29Richardson DerrickBuy42.80K——
2025-07-29Schroer John R.Buy111.95K$3.95442.20K
2025-07-29Schroer John R.Buy28.00K——
2025-07-29Hardiman Roy C.Buy28.00K——
2025-07-29Hardiman Roy C.Buy111.95K$3.95442.20K
2025-07-29Goldstein David MBuy107.95K$3.95426.40K
2025-07-29Goldstein David MBuy27.00K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 213, holders +1 vs prior quarter. Ownership 95.02%.

HolderSharesChangeChange %Value
AYURMAYA CAPITAL MANAGEMENT COMPANY, LP15.14M00.00%426.03M
BLACKROCK, INC.8.22M1.05M+14.60%231.26M
FMR LLC6.77M5.80M+595.14%190.48M
DEEP TRACK CAPITAL, LP6.35M-424.04K-6.26%178.65M
SAMSARA BIOCAPITAL, LLC6.35M00.00%178.55M
FORESITE CAPITAL MANAGEMENT V, LLC5.90M00.00%165.94M
PRICE T ROWE ASSOCIATES INC /MD/5.20M1.91M+58.21%146.32M
VENBIO PARTNERS LLC4.53M00.00%127.43M
FORESITE CAPITAL MANAGEMENT VI LLC4.25M00.00%119.53M
VANGUARD CAPITAL MANAGEMENT LLC4.22M183.44K+4.55%118.63M
NEXTECH INVEST LTD.3.54M00.00%99.64M
CORMORANT ASSET MANAGEMENT, LP3.29M-663.64K-16.80%92.46M
SATURN V CAPITAL MANAGEMENT LP2.92M-286.63K-8.95%82.04M
OCTAGON CAPITAL ADVISORS LP2.83M00.00%79.66M
JUPITER TOPCO LLC2.36M2.36MNew66.24M
STATE STREET CORP2.19M385.45K+21.39%61.55M
GEODE CAPITAL MANAGEMENT, LLC2.17M250.10K+13.04%61.03M
MPM BIOIMPACT LLC2.02M-367.51K-15.40%56.82M
BAKER BROS. ADVISORS LP2.01M00.00%56.63M
SR ONE CAPITAL MANAGEMENT, LP1.96M00.00%55.15M
INVESCO LTD.1.17M-338.02K-22.36%33.02M
NOVO HOLDINGS A/S1.10M1.10MNew30.95M
PRINCIPAL FINANCIAL GROUP INC1.07M10.01K+0.95%30.06M
D. E. SHAW & CO., INC.968.23K396.11K+69.23%27.25M
UBS GROUP AG951.80K-2.10M-68.84%26.78M

Earnings and financials

Alumis Inc. (ALMS) trades at $6.98, with a market cap of $903.46M and a trailing P/E of -1.78. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2022202320242025
00024050000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Alumis (ALMS) Financials: Revenue & Earnings

ALMS$6.98+0.34 +5.12%

$903.46M

Market Cap

-1.78

P/E

4.01

Forward P/E

47

Score

Price History